Objective: To develop and validate the RP- HPLC method for determining Luliconazole in bulk and pharmaceutical formulations. Methods: Following the International Conference on Harmonization (ICH) guidelines, a sensitive, accurate, and specific reversed-phase HPLC technique was created and validated for the detection of Luliconazole. Using high-performance liquid chromatography, this drug was examined. A better separation of the drug was achieved by using Agilent Eclipse XDB C (4.6mm x 250mm, 5µm) with a mobile phase consisting of a mixture of Acetonitrile and Buffer in HPLC water. The ratio of 30:70 v/v (Formic acid and Acetonitrile) at a flow rate of 1.0 ml/ min and the detection was at the wavelength 295 nm using a Photodiode Arrays Detector. The planned method was able to produce good quality separation of the drug and its degradation products with sharp peaks. Findings: Luliconazole had a retention time of 2.38 ± 0.127 minutes. The technique was linear in the range of 10-100 µg/ml, with a correlation (r2) of 0.9995 and a run duration of 4 minutes. The method limit of detection (LOD) and limit of quantification (LOQ) were set at 0.1 and 1 g/ml, respectively. The method accuracy and system precision were estimated, and the findings were calculated as percentage RSD values, which were found to be limitations. Luliconazole recovery was 100% confirming the method's efficiency. Novelty: The presented approach was innovative and successfully fulfilled all validation requirements, including linearity, robustness, accuracy, reduced retention, and run time. This suggests that the method is appropriate for identifying the stability of luliconazole in bulk and pharmaceutical formulations. Keywords: RP-HPLC, Transferosome, ICH guidelines, Validation, Luliconazole